NeurologyLive Friday 5 — December 18, 2020

December 18, 2020
NeurologyLive Staff

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending December 18, 2020.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Peer Exchange — TRIUMPHANT-MS Trial: Fatigue in MS

A panel of MS experts debates the results of the TRIUMPHANT-MS clinical trial of 3 commonly used medications for the treatment of MS-related fatigue (amantadine, modafinil, methylphenidate) vs placebo in fatigued subjects with MS.

2: NeuroVoices: Eric Segal, MD, on Real-World Use of Diazepam Nasal Spray

Eric Segal, MD, director of pediatric epilepsy, HMH Hackensack University Medical Center, detailed his study on diazepam nasal spray in patients with and without antiseizure medications.

3: Mind Moments: Aducanumab and Alzheimer Disease Clinical Trials

As part of a NeurologyLive series on aducanumab's journey to the FDA and the challenges of conducting clinical trials in Alzheimer disease, Mind Moments episode 24 features interviews with Lon Schneider, MD, MS; Marwan Sabbagh, MD; Stephen Salloway, MD, MS; Richard S. Isaacson, MD; and Anton Porsteinsson, MD.

4: Aparna V.R. Polavarapu, MD: Early Treatment for Infantile Spasms

The pediatric neurologist at Montefiore Health System explains the importance of treating infantile spasms as early as possible and how it may impact outcomes.

5: Expert Perspectives: The Importance of Patient Communication

Amaal J. Starling, MD, a key opinion leader in migraine, discusses the importance of patient communication when optimizing the efficacy of acute migraine treatment.